This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Doctors, 99% of whom were acting in good faith, determined the total volume of prescription opioids that pharmacies ordered from defendants and dispensed pursuant to those prescriptions,” Faber wrote in his opinion. These were doctors whose only goal was to make money. Once again money rules.
IN BRIEF: Pharma companies have been posting jobs on LinkedIn almost every day. While most offices remain closed pharma is preparing for the launch of new products and has to have the infrastructure to ensure a successful launch. This is a great time for people who want to be the change they want to see to work in pharma.
Rick Ratliff, a pharmacy industry veteran who was for a time CEO of Surescripts, built a national digital prescription network connecting doctors to pharmacies. The post Pivot Podcast: The Evolution of Pharmacies with Rick Ratliff appeared first on MedCity News.
Zoom Rx recently polled HCPs and found 78% of physicians want to maintain some contact with pharma reps. The most desired information doctors now want is about patient assistance programs, with 49% saying they want pharma reps to provide that information. doctors and 45% of all NPS and physician assistants as verified members.
SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. Today, people don’t see a DTC TV ad and run to their doctor to ask for an Rx. DTC ads do NOT lead to unnecessary Rxs.
We can apply this approach in pharma by enhancing our patient journey maps and go beyond focusing on the key clinical engagement touch points (e.g., doctor visits, prescription pickups) and enriching our insights with the micro-moments surrounding these obvious events.
Tik-Tok, Instagram, and other social media channels may soon be overwhelmed with pharma companies’ content, but is it a good idea? Pharma companies have policies that heavily restrict their use of social media and limit their ability to benefit from the wealth of data that could accompany it. What about social media options?
(Endpoints) Pharma TV advertising boomed in 2021 – to the tune of $3.91 billion across prescription meds, iSpot reports. year over year, which may not sound like much but marks pharma’s steady growth through the pandemic. The post Pharma spent $3.9B That’s an increase of 4.8% What a waste of money.
SUMMARY: Online health seeker numbers are still very high, indicating that people are doing their research first before asking for a prescription drug. Online health seekers trust pharma products but find product websites hard to read and inconsistent with their needs. Online ads for prescription drugs are unique.
1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. People don’t want to lose weight through diet and exercise if they can lose it through a prescription drug.
Table of Contents The Impact of a Pharma Ad Ban on TV Digital Marketing as a Primary Alternative Leveraging Data-Driven Advertising Strategies Strengthening Direct-to-Consumer (DTC) Engagement The Impact of a Pharma Ad Ban on TV The potential for a pharma ad ban on TV has sparked intense discussions among marketing executives.
Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales. Nowhere is this clearer than in pharma DTC TV ads. A Prevention Magazine study dated had prescription DTC ads as being 7% effective in driving new Rx’s. ” Ninety-two percent of U.S.
SUMMARY: “How big pharma takeovers destroy innovation” a report from Congresswoman Porter does make some points. I always have pointed instances in which pharma puts Wall Street first and patients second. I have worked with and stayed in contact with some R&D people within pharma and they have a different answer.
A website and TV commercials are not enough to get patients to ask for a prescription medication especially when fair balance lists side effects like cancer. For most a content strategy is unheard of and even though email marketing is still a very viable tactic pharma sees it as too complicated to measure the ROI.
Jazz Pharmaceuticals has introduced a new prescription medication for patients with sleep apnea/narcolepsy that “helped adults get up to 9 hours of improved wakefulness in clinical studies at 12 weeks” and they’re using a flying pig on their DTC. billion in 2018, and is expected to grow at a CAGR of 7.20% to reach $86.01
The shift to digital advertising doesn’t make sense when pharma product websites don’t meet consumers’ needs. There is a direct correlation between pharma product website traffic and TV ads for new products. The other mistake pharma marketers make the absence of a content strategy.
What is the definition of a successful pharma product launch? Pharma companies have been investing deeply into digital advertising but vastly under measuring customer engagement and other metrics. This is a massive issue for most big pharma companies because it often takes weeks of meetings to make even small changes.
First, the health insurance companies are making a lot of money while burying doctors in paperwork and limiting treatment options. Patients and doctors are tired, and insurance companies are raising rates after two years of making a surplus because nobody went to the doctor during the pandemic. The result:?
With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. So, how can pharma marketing teams maximize the impact of their Google Ads while staying compliant?
Yes, telehealth has grown substantially, but that’s because patients are afraid of going into doctor’s offices. Let’s be clear about pharma product websites. Most are OK with telehealth but don’t want patients using telehealth to ask for new prescriptions. Some are, but most aren’t.
Digital pharma marketers have to “sell” the organization on the promise of digital marketing, but they also need to communicate that along with successes, there could be many failures. To master digital marketing, pharma needs to be prepared to fail. I’m optimistic that pharma can make it happen.
Pharma product websites need to evolve and become a credible source of inline health information for people who are often lost in bad information online. Pharma product websites have always had one objective: get the website visitor to ask their doctor for an Rx. But Rich, we can’t compare pharma websites to CPG websites.
Among the 26% of respondents who talked to a health care provider about a specific prescription drug they saw advertised, 16% said they received a prescription for the advertised drug. Online research is used to evaluate new prescription drugs. But is this really true across all DTC? That belief is out the window.
Talented marketers don’t want a career in pharma because of the culture. Many pharma agencies have allowed and sometimes forced experienced, talented people to leave while replacing them with inexpensive unproven people, and it shows. 1ne: Pharma companies are forcing out older, experienced employees. Pure fantasy.
SUMMARY: According to eMarketer, “in 2020, spending on digital advertising in the healthcare and pharma industry will grow by 14.2% One area I do agree with them is that “healthcare and pharma will make up 7.1% to reach $9.53 this year). How reliable is this estimate? eMarketer has been wrong more times than I can count.
Despite a slew of prescription options and widespread advertising pushes, most patients are sticking with over-the-counter (OTC) remedies rather than trying new preventive medications, according to Phreesia Life Sciences’ survey results collected from more than 4,000 patients checking in for their doctors’ appointments in July 2021.
Understanding how to effectively engage HCPs in pharma marketing is essential for driving brand awareness, product education, and ultimately, prescription behavior. That shift demands a new approach to reaching HCPs in pharma marketing. In fact, over 60% of HCPs now prefer digital over in-person interactions.
Consistently we heard that they like images of real patients or a REAL doctor with one key message communicated. 9ine: “Why aren’t pharma websites updated?” Our groups thought pharma websites had a lot of credibility especially when our moderator informed them that the website had been approved by the FDA.
Consumers have changed their shopping behavior due to the pandemic, and some of those changes are relevant for pharma marketers. The days of someone seeing an ad for a prescription drug and rushing to ask their doctor about it have replaced the quest for more information, usually online.
Fourteen percent of US consumers reported lapses in access to or taking their prescription medications. Digital channels play a far greater role in communication between pharma companies and healthcare professionals than before the pandemic. . SUMMARY: Should pharma invest in digital to reach physicians?
Consumers would ask their doctor about an advertised prescription drug in a perfect world. Most patients said they had done more research online or talked to other patients about their experience before asking their doctor about the brand. In our REAL world, that isn’t the way it happens. The research was straightforward.
SUMMARY: People are going online more and more to sarch for health information after seeing a DTC pharma TV spot. Pharma websites are not consdiered a top resource for infromation on new products. TV spots are the number one way people learn about new pharma products. Their doctor was a distant second.
DTC marketers would like to think that patients ask for the advertised drug when visiting their doctor, but that’s largely untrue. While it’s true that traffic on pharma websites is good, how these websites affect behavior has changed. Online searches for health information remain brisk, according to Google.
Pharma websites provide the prescription that can help people overcome health problems but too often, they ignore the patient’s responsibility to lose weight and exercise. The FDA should require every pharma product website to devote part of its content to prevention and the importance of exercise.
Pharma TV ads drive people online to search for more information. Safety pages on Pharma product websites continue to have high utility. As we have seen over the past few years, Pharma companies are a business, a regulated business, but still a business. Prescription drugs are not the same as items found in a grocery store.
But do doctors trust the system? consumers’ trust in pharma is low, despite the industry’s contributions to ending the pandemic: Only 15% of U.S. consumers say they trust pharma companies more than they did before the COVID-19 pandemic, according to Accenture’s 2021 survey. Physician trust in the U.S.
KEY TAKEAWAY: Consumer behavior has changed due to the pandemic, and DTC marketers should be aware of how consumers will evaluate and choose prescription drugs. Yes, the telehealth numbers are high, but they will level off when people feel safe to go back to their doctor. 10en : Expect the media to be hostile towards pharma.
Pity the poor pharma brand marketer. Should pharma brand campaigns drive quality, affinity, or persuasion? Survey Reveals Why Brand Building Matters Two big themes emerge that distinguish pharma marketing. First, pharma categories are dominated by the top 20% of prescribers. Brand-building campaigns!
One study analyzed the drug ads of an anti-hypertensive drug in 210 issues of the NEJM between 1985 to 1996 and showed increased ad frequency was associated with an increase in prescriptions. You can give them a list of doctors to target, and they will report metrics on how many of them have engaged your content. But what about online?
The rapid rollout of Covid-19 vaccines has made household names of Pfizer and AstraZeneca, and the whole industry is winning praise for co-operation” However, the bump in reputation will be short-lived because companies need to earn the public’s trust every day, and pharma is already damaging their perception with people.
SUMMARY: Both emergency room visits and doctors’ visits are down by about half because people are putting off treatment for medical emergencies due to fears of contracting COVID-19. How is pharma going to get patients back into to ask their doctor about branded medications?
However, despite being one of the biggest markets in pharma, diabetes drugmakers have a hard time standing out in the crowded field, and many patients still aren’t confident in their ability to manage their disease. Patients are willing to explore new prescription therapies as well, but most are unaware of their available options.
QUICK READ: The compensation for pharma CEOs is starting to be reported and it’s off the charts. Pharma, PBM, and health insurance CEOs earn hundreds of millions of dollars to do one thing; make their companies a lot of money. There is a new breed of pharma CEO coming I believe. Bob Bradway of Amgen bagged a $20.1
Typically, results or new treatment prescriptions are simply uploaded to the portal with the doctors expected to give explanations during the appointment—even though the ability to provide additional information within the portal is readily available. However, only 32% of patients trust pharma-developed apps.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content